- published: 02 Feb 2016
- views: 134
Create your page here
-
remove the playlistAmgen
- remove the playlistAmgen
back to playlist
In just one year Amgen successfully launched an unprecedented six new products; grew our business, adding new and leveraging legacy products; defended products against our competitors; advanced our pipeline, our biosimilars portfolio and geographic scope; and continued to transform Amgen to reach its full potential and build a better company for the future. Amgen’s CEO Bob Bradway and members of his senior team prepared this summary video for staff members, which is published here.
Amgen staff members discuss innovation in manufacturing biologic medicines.
http://www.BiotechnologybyAmgen.com
- published: 31 May 2013
- views: 12521
Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
http://www.Amgen.com
- published: 21 Jul 2014
- views: 2843
Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had major impact on the success of his biotech firm, as well as the mission critical issues of intellectual property rights protection and safety issues.
- published: 17 Oct 2012
- views: 1886
Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen staff from around the world share their thoughts on the corporate values that set the company apart and make working at Amgen more than just a job. Read more about the Amgen Values here:http://amgen.com/careers/values.html
- published: 04 Jun 2012
- views: 30561
Biologic therapies are typically derived from living organisms. They are made by genetically engineering living cells, and a high level of precision is required in the commercial manufacturing process to produce a consistent biologic product each time. The protein produced by the cells will be influenced by individual cell characteristics, and the environment and nutrients provided during the manufacturing process.
- published: 10 May 2012
- views: 20345
A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyists) used financial contributions to Congress to pump up their profits at the expense of Medicare. The Young Turks host Cenk Uygur breaks it down.
Read the NY Times piece here from ERIC LIPTON and KEVIN SACK: http://www.nytimes.com/2013/01/23/opinion/amgen-gets-a-gift-from-congress.html
Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube
Like Us on Facebook:
Follow Us on Twitter: http://bit.ly/OkX87X
Buy TYT Merch: http://theyoungturks.spreadshirt.com/
- published: 23 Jan 2013
- views: 43772
Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses science and innovation to dramatically improve people’s lives, and our mission to serve patients attracts a workforce committed to making a difference for others. Making that positive difference is ingrained in Amgen’s business and culture, and includes our philanthropic efforts, our commitments to give back to the communities in which we live and work, and our environmental sustainability initiatives. Through the Amgen Foundation, we’re inspiring the next generation of innovators by advancing science education programming globally. In addition, Amgen staff members devote tens of thousands of volunteer hours to support local community activities throughout the world. Amgen is also committed to environmentally responsible operations, which includes using natural resources wisely and considering our overall impact on the environment.
- published: 29 Mar 2016
- views: 56
Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the science behind biologics. The more we understand how the human body works the better our chances of developing new medicines that improve patient care.
- published: 14 Mar 2013
- views: 1598
Amgen (NASDAQ: AMGN, SEHK: 4332) is an American-based multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. Epogen and Neupogen (the company's first products on the market) were the two most successful biopharmaceutical products at the time of their respective releases.
Amgen is the largest employer in Thousand Oaks and second only to the United States Navy in terms of number of people employed in Ventura County. BusinessWeek ranked Amgen first on the S&P 500 for being one of the most "future-oriented" of those five hundred corporations.BusinessWeek ostensibly calculated the ratio of research and development spending, combined with capital spending, to total outlays; Amgen had the fourth highest ratio, at 506:1000.
The company employs approximately 17,000 staff members. Its products include Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA. Amgen has several collaborative arrangement with Pfizer Inc, GlaxoSmithKline, Takeda Pharmaceutical Company, Kyowa Hakko Kirin, Daiichi Sankyo and Array BioPharma. It is a leading member of the U.S. Global Leadership Coalition, a coalition of over 400 companies and NGOs that promotes increased funding for US diplomatic and international development programs. In 2010, Amgen began sponsoring the Tour of California, one of only three major Union Cycliste Internationale events in the United States.
This page contains text from Wikipedia, the Free Encyclopedia -
http://en.wikipedia.org/wiki/Amgen
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
3:232015 Year in Review – A Message to Staff From Amgen’s Leadership
2015 Year in Review – A Message to Staff From Amgen’s Leadership2015 Year in Review – A Message to Staff From Amgen’s Leadership
In just one year Amgen successfully launched an unprecedented six new products; grew our business, adding new and leveraging legacy products; defended products against our competitors; advanced our pipeline, our biosimilars portfolio and geographic scope; and continued to transform Amgen to reach its full potential and build a better company for the future. Amgen’s CEO Bob Bradway and members of his senior team prepared this summary video for staff members, which is published here. -
2:13Biotechnology by Amgen: Innovation
Biotechnology by Amgen: InnovationBiotechnology by Amgen: Innovation
Amgen staff members discuss innovation in manufacturing biologic medicines. http://www.BiotechnologybyAmgen.com -
2:41Amgen Science
Amgen Science -
1:36About Amgen
About AmgenAbout Amgen
Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. http://www.Amgen.com -
6:21Strategic Business Insights: An interview with Amgen CEO Kevin Sharer
Strategic Business Insights: An interview with Amgen CEO Kevin SharerStrategic Business Insights: An interview with Amgen CEO Kevin Sharer
Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had major impact on the success of his biotech firm, as well as the mission critical issues of intellectual property rights protection and safety issues. -
2:23The Amgen Difference
The Amgen DifferenceThe Amgen Difference
Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen staff from around the world share their thoughts on the corporate values that set the company apart and make working at Amgen more than just a job. Read more about the Amgen Values here:http://amgen.com/careers/values.html -
5:09The Challenges in Manufacturing Biologics
The Challenges in Manufacturing BiologicsThe Challenges in Manufacturing Biologics
Biologic therapies are typically derived from living organisms. They are made by genetically engineering living cells, and a high level of precision is required in the commercial manufacturing process to produce a consistent biologic product each time. The protein produced by the cells will be influenced by individual cell characteristics, and the environment and nutrients provided during the manufacturing process. -
2:10Amgen Internship Video - Why Amgen?
Amgen Internship Video - Why Amgen?Amgen Internship Video - Why Amgen?
-
10:00Disturbing Report: Both Parties In Bed With Amgen
Disturbing Report: Both Parties In Bed With AmgenDisturbing Report: Both Parties In Bed With Amgen
A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyists) used financial contributions to Congress to pump up their profits at the expense of Medicare. The Young Turks host Cenk Uygur breaks it down. Read the NY Times piece here from ERIC LIPTON and KEVIN SACK: http://www.nytimes.com/2013/01/23/opinion/amgen-gets-a-gift-from-congress.html Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube Like Us on Facebook: Follow Us on Twitter: http://bit.ly/OkX87X Buy TYT Merch: http://theyoungturks.spreadshirt.com/ -
3:12Amgen Corporate Social Responsibility
Amgen Corporate Social ResponsibilityAmgen Corporate Social Responsibility
Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses science and innovation to dramatically improve people’s lives, and our mission to serve patients attracts a workforce committed to making a difference for others. Making that positive difference is ingrained in Amgen’s business and culture, and includes our philanthropic efforts, our commitments to give back to the communities in which we live and work, and our environmental sustainability initiatives. Through the Amgen Foundation, we’re inspiring the next generation of innovators by advancing science education programming globally. In addition, Amgen staff members devote tens of thousands of volunteer hours to support local community activities throughout the world. Amgen is also committed to environmentally responsible operations, which includes using natural resources wisely and considering our overall impact on the environment. -
5:33Amgen Tour of California 2015 - Stage 7 - Finish
Amgen Tour of California 2015 - Stage 7 - Finish -
2:08Dr. Joe Miletich of Amgen explains biologics, why the future is promising
Dr. Joe Miletich of Amgen explains biologics, why the future is promisingDr. Joe Miletich of Amgen explains biologics, why the future is promising
Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the science behind biologics. The more we understand how the human body works the better our chances of developing new medicines that improve patient care.
- Acorda Therapeutics
- Activision Blizzard
- Adobe Systems
- Adolor Corporation
- Akamai Technologies
- Alcon
- Alkermes (company)
- Allergan
- Altera
- Alza
- Amazon.com
- Amgen
- Anakinra
- Anemia
- Apollo Group
- Apple Inc.
- Applied Materials
- Approved drug
- Aranesp
- Arthritis
- ARYx Therapeutics
- Asset
- Autodesk
- Avago Technologies
- Avax Technologies
- AVI BioPharma
- Baidu
- Barr Pharmaceuticals
- Baxter International
- Bed Bath & Beyond
- Biogen Idec
- Biolex
- Biopharmaceutical
- Biotechnology
- Biovest
- Biovista
- BMC Software
- Bristol-Myers Squibb
- Broadcom
- BusinessWeek
- CA Technologies
- CancerVax
- Celgene
- Cephalon
- Cerner
- Chairman
- Check Point
- Cinacalcet
- Cisco Systems
- Citrix Systems
- Clinical trial
- Colon cancer
- Combe Incorporated
- Comcast
- Conejo Valley
- Corporation
- Costco
- CoTherix
- Covance
- Covidien
- Ctrip
- Cutter Laboratories
- CytoSport
- CytRx
- Daiichi Sankyo
- Danco Laboratories
- Darbepoetin
- Darbepoetin alfa
- Dell
- Denosumab
- Dentsply
- DirecTV
- DNAPrint Genomics
- Dollar Tree
- Drug discovery
- EBay
- Electronic Arts
- Elorac
- Enbrel
- Endo Pharmaceuticals
- Epoetin
- Epogen
- Equity (finance)
- Etanercept
- Ethicon Endo-Surgery
- Ethicon Inc.
- Expedia, Inc.
- Express Scripts
- F5 Networks
- Fastenal
- Filgrastim
- Fiserv
- Flextronics
- Forest Laboratories
- Fossil, Inc.
- Fox Field
- Garmin
- Genentech
- Genta (company)
- GenVec
- Gilead Sciences
- GlaxoSmithKline
- Gordon Binder
- Gulfstream V
- Henry Schein
- Hospira
- House of Lords
- ImClone Systems
- Infosys
- Intel Corporation
- Intuit
- Intuitive Surgical
- ISTA Pharmaceuticals
- Ivax Corporation
- Johnson & Johnson
- Kevin W. Sharer
- Kinetic Concepts
- King Pharmaceuticals
- Kinray
- KLA Tencor
- KV Pharmaceutical
- Kyowa Hakko Kirin
- Lam Research
- Liberty Interactive
- Life Technologies
- Linear Technology
- Mattel
- McKesson Corporation
- McNeil Laboratories
- Melior Discovery
- Mentholatum
- Merck & Co.
- Microchip Technology
- Micron Technology
- Microsoft
- Miles Laboratories
- Mimpara
- Monster Beverage
- Mylan
- Myriad Genetics
- NASDAQ
- NASDAQ-100
- Net income
- NetApp
- Netflix
- Neulasta
- Neupogen
- Neutropenia
- News Corporation
- Nplate
- Nuvelo
- Nvidia
- O'Reilly Auto Parts
- Oracle Corporation
- Oral mucositis
- Ortho Pharmaceutical
- OSI Pharmaceuticals
- Osteoporosis
- Paccar
- Palifermin
- Panitumumab
- Par Pharmaceutical
- Parke-Davis
- Patent
- Paychex
- Perrigo
- Pfizer
- Pfizer Inc
- Pharmacology
- Portal California
- Portal Companies
- Portmanteau
- Prasco Laboratories
- President
- Priceline.com
- Procter & Gamble
- Product (business)
- Prolia
- Proteon Therapeutics
- Public company
- Purdue Pharma
- Qualcomm
- Qualitest
- Randgold Resources
- Ratio
- Regeneron
- Repros Therapeutics
- Research In Motion
- Rheumatoid arthritis
- Romiplostim
- Ross Stores
- S&P; 500
- SanDisk
- Savage Laboratories
- Schering-Plough
- Seagate Technology
- Sensipar
- Sigma-Aldrich
- Sirius XM Radio
- Staples Inc.
- Starbucks
- Stericycle
- Sterling Drug
- Symantec
- Tanox
- Tec Laboratories
- Template NASDAQ-100
- Texas Instruments
- Ticker symbol
- Tiens Biotech Group
- Tour of California
- Trevena Inc
- Trubion
- United Kingdom
- United States
- United States Dollar
- United States Navy
- Upjohn
- Vectibix
- Ventria Bioscience
- Verisign
- Virgin Media
- ViroPharma
- Vodafone
- Warner Chilcott
- Whole Foods Market
- Wyeth
- Wynn Resorts
- Xgeva
- Xilinx
- Yahoo!
-
2015 Year in Review – A Message to Staff From Amgen’s Leadership
In just one year Amgen successfully launched an unprecedented six new products; grew our business, adding new and leveraging legacy products; defended products against our competitors; advanced our pipeline, our biosimilars portfolio and geographic scope; and continued to transform Amgen to reach its full potential and build a better company for the future. Amgen’s CEO Bob Bradway and members of his senior team prepared this summary video for staff members, which is published here. -
Biotechnology by Amgen: Innovation
Amgen staff members discuss innovation in manufacturing biologic medicines. http://www.BiotechnologybyAmgen.com -
-
About Amgen
Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. http://www.Amgen.com -
Strategic Business Insights: An interview with Amgen CEO Kevin Sharer
Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had major impact on the success of his biotech firm, as well as the mission critical issues of intellectual property rights protection and safety issues. -
The Amgen Difference
Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen staff from around the world share their thoughts on the corporate values that set the company apart and make working at Amgen more than just a job. Read more about the Amgen Values here:http://amgen.com/careers/values.html -
The Challenges in Manufacturing Biologics
Biologic therapies are typically derived from living organisms. They are made by genetically engineering living cells, and a high level of precision is required in the commercial manufacturing process to produce a consistent biologic product each time. The protein produced by the cells will be influenced by individual cell characteristics, and the environment and nutrients provided during the manufacturing process. -
Amgen Internship Video - Why Amgen?
-
Disturbing Report: Both Parties In Bed With Amgen
A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyists) used financial contributions to Congress to pump up their profits at the expense of Medicare. The Young Turks host Cenk Uygur breaks it down. Read the NY Times piece here from ERIC LIPTON and KEVIN SACK: http://www.nytimes.com/2013/01/23/opinion/amgen-gets-a-gift-from-congress.html Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube Like Us on Facebook: Follow Us on Twitter: http://bit.ly/OkX87X Buy TYT Merch: http://theyoungturks.spreadshirt.com/ -
Amgen Corporate Social Responsibility
Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses science and innovation to dramatically improve people’s lives, and our mission to serve patients attracts a workforce committed to making a difference for others. Making that positive difference is ingrained in Amgen’s business and culture, and includes our philanthropic efforts, our commitments to give back to the communities in which we live and work, and our environmental sustainability initiatives. Through the Amgen Foundation, we’re inspiring the next generation of innovators by advancing science education programming globally. In addition, Amgen staff members devote tens of thousands of volunteer hours to support local community activities throughout the world. Amgen is also committed to environme... -
-
Dr. Joe Miletich of Amgen explains biologics, why the future is promising
Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the science behind biologics. The more we understand how the human body works the better our chances of developing new medicines that improve patient care.
2015 Year in Review – A Message to Staff From Amgen’s Leadership
- Order: Reorder
- Duration: 3:23
- Updated: 02 Feb 2016
- views: 134
In just one year Amgen successfully launched an unprecedented six new products; grew our business, adding new and leveraging legacy products; defended products ...
In just one year Amgen successfully launched an unprecedented six new products; grew our business, adding new and leveraging legacy products; defended products against our competitors; advanced our pipeline, our biosimilars portfolio and geographic scope; and continued to transform Amgen to reach its full potential and build a better company for the future. Amgen’s CEO Bob Bradway and members of his senior team prepared this summary video for staff members, which is published here.
wn.com/2015 Year In Review – A Message To Staff From Amgen’S Leadership
In just one year Amgen successfully launched an unprecedented six new products; grew our business, adding new and leveraging legacy products; defended products against our competitors; advanced our pipeline, our biosimilars portfolio and geographic scope; and continued to transform Amgen to reach its full potential and build a better company for the future. Amgen’s CEO Bob Bradway and members of his senior team prepared this summary video for staff members, which is published here.
- published: 02 Feb 2016
- views: 134
Biotechnology by Amgen: Innovation
- Order: Reorder
- Duration: 2:13
- Updated: 31 May 2013
- views: 12521
Amgen staff members discuss innovation in manufacturing biologic medicines.
http://www.BiotechnologybyAmgen.com
Amgen staff members discuss innovation in manufacturing biologic medicines.
http://www.BiotechnologybyAmgen.com
wn.com/Biotechnology By Amgen Innovation
Amgen staff members discuss innovation in manufacturing biologic medicines.
http://www.BiotechnologybyAmgen.com
- published: 31 May 2013
- views: 12521
Amgen Science
- Order: Reorder
- Duration: 2:41
- Updated: 12 Feb 2015
- views: 10179
Some of the greatest advances in science are unfolding now inside Amgen. Watch the future of biotechnology as it unfolds and hear stories from the scientists ma...
Some of the greatest advances in science are unfolding now inside Amgen. Watch the future of biotechnology as it unfolds and hear stories from the scientists making it happen at http://www.AmgenScience.com.
wn.com/Amgen Science
About Amgen
- Order: Reorder
- Duration: 1:36
- Updated: 21 Jul 2014
- views: 2843
Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufac...
Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
http://www.Amgen.com
wn.com/About Amgen
Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
http://www.Amgen.com
- published: 21 Jul 2014
- views: 2843
Strategic Business Insights: An interview with Amgen CEO Kevin Sharer
- Order: Reorder
- Duration: 6:21
- Updated: 17 Oct 2012
- views: 1886
Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had major impact on the success of his biotech firm, as well as the missi...
Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had major impact on the success of his biotech firm, as well as the mission critical issues of intellectual property rights protection and safety issues.
wn.com/Strategic Business Insights An Interview With Amgen Ceo Kevin Sharer
Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had major impact on the success of his biotech firm, as well as the mission critical issues of intellectual property rights protection and safety issues.
- published: 17 Oct 2012
- views: 1886
The Amgen Difference
- Order: Reorder
- Duration: 2:23
- Updated: 04 Jun 2012
- views: 30561
Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen staff from around the world share their thoughts on the corporate values...
Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen staff from around the world share their thoughts on the corporate values that set the company apart and make working at Amgen more than just a job. Read more about the Amgen Values here:http://amgen.com/careers/values.html
wn.com/The Amgen Difference
Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen staff from around the world share their thoughts on the corporate values that set the company apart and make working at Amgen more than just a job. Read more about the Amgen Values here:http://amgen.com/careers/values.html
- published: 04 Jun 2012
- views: 30561
The Challenges in Manufacturing Biologics
- Order: Reorder
- Duration: 5:09
- Updated: 10 May 2012
- views: 20345
Biologic therapies are typically derived from living organisms. They are made by genetically engineering living cells, and a high level of precision is required...
Biologic therapies are typically derived from living organisms. They are made by genetically engineering living cells, and a high level of precision is required in the commercial manufacturing process to produce a consistent biologic product each time. The protein produced by the cells will be influenced by individual cell characteristics, and the environment and nutrients provided during the manufacturing process.
wn.com/The Challenges In Manufacturing Biologics
Biologic therapies are typically derived from living organisms. They are made by genetically engineering living cells, and a high level of precision is required in the commercial manufacturing process to produce a consistent biologic product each time. The protein produced by the cells will be influenced by individual cell characteristics, and the environment and nutrients provided during the manufacturing process.
- published: 10 May 2012
- views: 20345
Amgen Internship Video - Why Amgen?
- Order: Reorder
- Duration: 2:10
- Updated: 15 Jul 2015
- views: 154
- published: 15 Jul 2015
- views: 154
Disturbing Report: Both Parties In Bed With Amgen
- Order: Reorder
- Duration: 10:00
- Updated: 23 Jan 2013
- views: 43772
A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyists) used financial contributions to Congress to pump up their profits a...
A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyists) used financial contributions to Congress to pump up their profits at the expense of Medicare. The Young Turks host Cenk Uygur breaks it down.
Read the NY Times piece here from ERIC LIPTON and KEVIN SACK: http://www.nytimes.com/2013/01/23/opinion/amgen-gets-a-gift-from-congress.html
Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube
Like Us on Facebook:
Follow Us on Twitter: http://bit.ly/OkX87X
Buy TYT Merch: http://theyoungturks.spreadshirt.com/
wn.com/Disturbing Report Both Parties In Bed With Amgen
A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyists) used financial contributions to Congress to pump up their profits at the expense of Medicare. The Young Turks host Cenk Uygur breaks it down.
Read the NY Times piece here from ERIC LIPTON and KEVIN SACK: http://www.nytimes.com/2013/01/23/opinion/amgen-gets-a-gift-from-congress.html
Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube
Like Us on Facebook:
Follow Us on Twitter: http://bit.ly/OkX87X
Buy TYT Merch: http://theyoungturks.spreadshirt.com/
- published: 23 Jan 2013
- views: 43772
Amgen Corporate Social Responsibility
- Order: Reorder
- Duration: 3:12
- Updated: 29 Mar 2016
- views: 56
Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses science and innovation to dramatically improve people’s lives, and our m...
Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses science and innovation to dramatically improve people’s lives, and our mission to serve patients attracts a workforce committed to making a difference for others. Making that positive difference is ingrained in Amgen’s business and culture, and includes our philanthropic efforts, our commitments to give back to the communities in which we live and work, and our environmental sustainability initiatives. Through the Amgen Foundation, we’re inspiring the next generation of innovators by advancing science education programming globally. In addition, Amgen staff members devote tens of thousands of volunteer hours to support local community activities throughout the world. Amgen is also committed to environmentally responsible operations, which includes using natural resources wisely and considering our overall impact on the environment.
wn.com/Amgen Corporate Social Responsibility
Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses science and innovation to dramatically improve people’s lives, and our mission to serve patients attracts a workforce committed to making a difference for others. Making that positive difference is ingrained in Amgen’s business and culture, and includes our philanthropic efforts, our commitments to give back to the communities in which we live and work, and our environmental sustainability initiatives. Through the Amgen Foundation, we’re inspiring the next generation of innovators by advancing science education programming globally. In addition, Amgen staff members devote tens of thousands of volunteer hours to support local community activities throughout the world. Amgen is also committed to environmentally responsible operations, which includes using natural resources wisely and considering our overall impact on the environment.
- published: 29 Mar 2016
- views: 56
Amgen Tour of California 2015 - Stage 7 - Finish
- Order: Reorder
- Duration: 5:33
- Updated: 16 May 2015
- views: 68621
Join us at: https://facebook.com/PeterSagFan and
Follow us on Twitter: https://twitter.com/Peter_SagFan
Join us at: https://facebook.com/PeterSagFan and
Follow us on Twitter: https://twitter.com/Peter_SagFan
wn.com/Amgen Tour Of California 2015 Stage 7 Finish
Dr. Joe Miletich of Amgen explains biologics, why the future is promising
- Order: Reorder
- Duration: 2:08
- Updated: 14 Mar 2013
- views: 1598
Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the science behind biologics. The more we understand how the human body wo...
Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the science behind biologics. The more we understand how the human body works the better our chances of developing new medicines that improve patient care.
wn.com/Dr. Joe Miletich Of Amgen Explains Biologics, Why The Future Is Promising
Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the science behind biologics. The more we understand how the human body works the better our chances of developing new medicines that improve patient care.
- published: 14 Mar 2013
- views: 1598
close fullscreen
- Playlist
- Chat
close fullscreen
- Playlist
- Chat
3:23
2015 Year in Review – A Message to Staff From Amgen’s Leadership
In just one year Amgen successfully launched an unprecedented six new products; grew our b...
published: 02 Feb 2016
2015 Year in Review – A Message to Staff From Amgen’s Leadership
2015 Year in Review – A Message to Staff From Amgen’s Leadership
- Report rights infringement
- published: 02 Feb 2016
- views: 134
2:13
Biotechnology by Amgen: Innovation
Amgen staff members discuss innovation in manufacturing biologic medicines.
http://www.Bio...
published: 31 May 2013
Biotechnology by Amgen: Innovation
Biotechnology by Amgen: Innovation
- Report rights infringement
- published: 31 May 2013
- views: 12521
2:41
Amgen Science
Some of the greatest advances in science are unfolding now inside Amgen. Watch the future ...
published: 12 Feb 2015
Amgen Science
Amgen Science
- Report rights infringement
- published: 12 Feb 2015
- views: 10179
1:36
About Amgen
Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patient...
published: 21 Jul 2014
About Amgen
About Amgen
- Report rights infringement
- published: 21 Jul 2014
- views: 2843
6:21
Strategic Business Insights: An interview with Amgen CEO Kevin Sharer
Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had...
published: 17 Oct 2012
Strategic Business Insights: An interview with Amgen CEO Kevin Sharer
Strategic Business Insights: An interview with Amgen CEO Kevin Sharer
- Report rights infringement
- published: 17 Oct 2012
- views: 1886
2:23
The Amgen Difference
Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen st...
published: 04 Jun 2012
The Amgen Difference
The Amgen Difference
- Report rights infringement
- published: 04 Jun 2012
- views: 30561
5:09
The Challenges in Manufacturing Biologics
Biologic therapies are typically derived from living organisms. They are made by genetical...
published: 10 May 2012
The Challenges in Manufacturing Biologics
The Challenges in Manufacturing Biologics
- Report rights infringement
- published: 10 May 2012
- views: 20345
2:10
Amgen Internship Video - Why Amgen?
published: 15 Jul 2015
Amgen Internship Video - Why Amgen?
Amgen Internship Video - Why Amgen?
- Report rights infringement
- published: 15 Jul 2015
- views: 154
10:00
Disturbing Report: Both Parties In Bed With Amgen
A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyist...
published: 23 Jan 2013
Disturbing Report: Both Parties In Bed With Amgen
Disturbing Report: Both Parties In Bed With Amgen
- Report rights infringement
- published: 23 Jan 2013
- views: 43772
3:12
Amgen Corporate Social Responsibility
Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses sc...
published: 29 Mar 2016
Amgen Corporate Social Responsibility
Amgen Corporate Social Responsibility
- Report rights infringement
- published: 29 Mar 2016
- views: 56
5:33
Amgen Tour of California 2015 - Stage 7 - Finish
Join us at: https://facebook.com/PeterSagFan and
Follow us on Twitter: https://twitter.co...
published: 16 May 2015
Amgen Tour of California 2015 - Stage 7 - Finish
Amgen Tour of California 2015 - Stage 7 - Finish
- Report rights infringement
- published: 16 May 2015
- views: 68621
2:08
Dr. Joe Miletich of Amgen explains biologics, why the future is promising
Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the ...
published: 14 Mar 2013
Dr. Joe Miletich of Amgen explains biologics, why the future is promising
Dr. Joe Miletich of Amgen explains biologics, why the future is promising
- Report rights infringement
- published: 14 Mar 2013
- views: 1598
2015 Year in Review – A Message to Staff From Amge...
Biotechnology by Amgen: Innovation...
Amgen Science...
About Amgen...
Strategic Business Insights: An interview with Amg...
The Amgen Difference...
The Challenges in Manufacturing Biologics...
Amgen Internship Video - Why Amgen?...
Disturbing Report: Both Parties In Bed With Amgen...
Amgen Corporate Social Responsibility...
Amgen Tour of California 2015 - Stage 7 - Finish...
Dr. Joe Miletich of Amgen explains biologics, why ...
-
Lyrics list:lyrics
-
Shorty (You Keep Playin' With My Mind)
-
No Love
-
Love Letter
-
I'm Feelin You
-
Flava
-
No Doubt
-
You're The Bomb
-
Keep it to yourself
-
I Don't Wanna Play Basketball
-
Ever Again
-
-
-
-
-
-
-
-
-
Shorty (You Keep Playin' With My Mind)
featuring Keith Murray
1 - Shorty you keep playin' with my mind
You tease me all the time but I had enough
Maybe I should ask your girlfriends why
Why you are so afraid to fall in love
Girl I won't get next to you
You know I don't like sweatin' you
But something 'bout the way you make me feel
You got me in this fantasy
And all my friends keep tellin' me
Shorty's kinda hot, so what's the deal?
2 - Cuz we been spendin', rollin', livin', showin'
We got some time for play
But you've been player hatin', waitin'
For this rhyme to pass away
Repeat 1
You only get the best with me
I wanna give you everything
And anything you ask of me I will
And I don't want to front on you
So tell me what you wanna do
And if I'm not the one
Just keep it real
Repeat 2
Repeat 1
[Keith Murray]
Now first of all baby, what's my name?
Spell it backwards you read game
I'm known for splittin' wigs and readin' brains
And when I say splittin' wigs and readin' brains
I mean breakin' it down conversation-wise
Let me explain
I'm in your corner, girl be on my team
Together we could fulfill each other's life dream
We both Gemini so we got 2 sides
Our zodiac sign is the perfect sign
Cuz she replied, ";All Gemini's lie";
I guess this is what it feels like when doves cry
Your attitude is deep cover
Won't give me the number
Cold play me out like a foul, a bleep or a blunder
It's like a burnin' in the chest, a cardiac arrest
You look like you havin' fun puttin' me thru stress
So in between time and in the meantime
You do your thing and I do mine
But don't play wit my mind
Shorty, shorty
Won't you please get naughty with me
And if you really wanna
I can be your fantasy
You are so afraid, oh baby
Repeat 1 until fade
photo: US Navy / MCS1 Brett Cote
Tensions Grow As US Navy Warship Sails Close To Disputed Chinese Island
Edit WorldNews.com 10 May 2016
Tensions in the South China Sea ratcheted up on Tuesday as a U.S. Navy warship sailed within 12 nautical miles of a disputed island claimed by China, Time Magazine reports via Reuters.Officials say the U.S. move is sure to spark outrage from Beijing as China is protective of its claim.Department of Defense spokesperson Bill Urban told Reuters the USS William P ... in the disputed area ... The U.S....
photo: Creative Commons / Thelmadatter
Boy wonder may have discovered lost Mayan city
Edit CBS News 10 May 2016
Acting on a hunch, a 15-year-old from Canada may have discovered a long lost Mayan city buried beneath the jungle ... ....
photo: AP / Alastair Grant
Queen says Chinese officials were 'very rude' during Xi Jinping's state visit
Edit The Guardian 11 May 2016
‘Oh, bad luck,’ Queen tells police commander in charge of visit security, in off-guard moment caught on camera at Buckingham Palace garden party. The “golden era” of UK-China relations appears to have lost some of its glitter after the Queen accused Chinese officials of being “very rude” to the British ambassador during president Xi Jinping’s first state visit to Britain last year ... “Oh, bad luck.”. Related ... Twitter ... Related ... Transcript ... ....
photo: AP / Israel Leal
Scientists Return To Gulf Crater Site To Study Rocks For Clues About Early Earth Life
Edit WorldNews.com 10 May 2016
A crater formed nearly 65 million years ago when a massive asteroid struck the Earth has drawn interest from scientists who are now digging deep into the Gulf of Mexico, ABC News reported Tuesday.A team consisting of 33 scientists from around the world are collecting rock samples from the Chicxulub impact crater in the Yucatán Peninsula that scientists believe could hold clues about the history of life on Earth....
photo: Facebook/Erin Elizabeth Photography
Australian mum reveals quintuplets in photo shoot
Edit BBC News 10 May 2016
An Australian mother who gave birth to quintuplets in January has released a photo shoot of her unlikely new arrivals. Perth resident Kim Tucci, 26, took just two minutes to give birth to her four daughters and one son, who were conceived naturally ... The chance of conceiving quintuplets naturally is about one in 55 million ... ....
« back to news headlines
DEVO: Blevins takes Peace Race win (USA Cycling Inc)
Edit Public Technologies 11 May 2016
(Source. USA Cycling Inc) (May 10, 2016) -Chris Blevins (Durango, Colo./Team Specialized Racing) won the five-stage Course de la Paix (Peace Race) in the Czech Republic, taking the victory by 24 seconds. JUNIOR MEN ... The U23 men will race the May 12-15 Rhonde Isere in France, the junior men will take on the May 15 Ronde van Lieshout in the Netherlands, while the women's program heads west for the May 14-16 AMGEN Tour of California....
Daily iNAV and Portfolio Disclosure (ISE - The Irish Stock Exchange plc)
Edit Public Technologies 11 May 2016
(Source. ISE - The Irish Stock Exchange plc). STOCK EXCHANGE ANNOUNCEMENT - FOR IMMEDIATE RELEASE. PIMCO Fixed Income Source ETFs Plc (the 'Fund'). PIMCO Sterling Short Maturity Source UCITS ETF. (the 'Sub-Fund'). Re. Daily iNAV and portfolio disclosure. 11 May 2016. ______________________________________________. iNAV per share. 101.240359 as of 16.30 GMT on 10 May. Number of outstanding shares. 1,393,496. Portfolio Disclosure ... AMGEN INC SR UNSEC....
Traffic Alert: Roads in Old Town Newhall to be Impacted during AMGEN Tour of California (City of Santa Clarita, CA)
Edit Public Technologies 10 May 2016
on Monday, May 16, 2016, several street closures will be in effect throughout Santa Clarita for the 2016 Amgen Tour of California. Over 100 cyclists participating in the Amgen Tour of California will race into Old Town Newhall in Santa Clarita from South Pasadena for the Stage 2 Finish on Monday, May 16....
Two PDA Leaders Recognized as Most Influential People in Drug Development and Manufacture in 2016 (PDA - Parenteral Drug Association)
Edit Public Technologies 10 May 2016
(PDA) is pleased to announce that its current volunteer Chair Martin Van Trieste (Amgen) and one of its past chairs, James Agalloco, have been recognized by The Medicine Maker among the 'top 100 most influential people in the world of drug development and manufacture.' ... VP of Quality at Amgen, was praised for his ......
Research and Markets - Global Cancer Immunotherapies Market 2016-2020 - Key Vendors are Amgen, Bristol-Myers ...
Edit PR Newswire 10 May 2016OPKO Announces Appointment of Thomas Nusbickel as Senior Vice President of Pharmaceutical Marketing and Market Access (Opko Health Inc)
Edit Public Technologies 10 May 2016
Nusbickel has over 25 years of pharmaceutical experience with established large companies, such as Hospira, Amgen and Abbott, with a career long focus on specialty products and nephrology. He has been involved in numerous product launches including serving as the global lead for Amgen's launch of Sensipar, and has deep connections with managed care organizations and with key nephrology opinion leaders....
Two PDA Leaders Recognized as Most Influential People in Drug Development and Manufacture in 2016
Edit PR Newswire 10 May 2016Oil surge, improved Chinese data boost Wall Street
Edit The Times of India 10 May 2016
New York, May 10, 2016 (AFP) - ... Markets also got a boost from a rebound in commodities led by oil prices ... It's a very good transition," Hogan said ... Medivation, the San Francisco biotech company developing cancer therapies, fell 0.9 percent after it said it was giving Pfizer and Amgen access to its books to support possible takeover bids ... ....
Foamix Reports First Quarter 2016 Financial Results and Provides Business Update
Edit Stockhouse 10 May 2016
REHOVOT, Israel, May 10, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ.FOMX) (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, announces financial results for the three months ended March 31, 2016 ... Management Overview ... Revenues ... 7014692 ... Vectibix® is a registered trademark of Amgen Inc....
Foamix Reports First Quarter 2016 Financial Results and Provides Business Update (Foamix Pharmaceuticals Ltd)
Edit Public Technologies 10 May 2016
(Source. Foamix Pharmaceuticals Ltd). REHOVOT, Israel, May 10, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd.(NASDAQ.FOMX) ('Foamix Pharmaceuticals'), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, announces financial results for the three months ended March 31, 2016 ... U.S ... Vectibix® is a registered trademark of Amgen Inc....
Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral (Amgen Inc)
Edit Public Technologies 09 May 2016
Amgen Inc). CAMBRIDGE, Mass., May 9, 2016 /PRNewswire/ -- Amgen (NASDAQ. AMGN) and LabCentral announced today that Platelet BioGenesis is an Amgen's 2016 winner of the highly competitive Golden Ticket award, which underwrites the cost of a lab bench for a Platelet BioGenesis scientist in LabCentral's open lab for one year ... About Amgen ... For more information, visit www.amgen.com and follow us on www.twitter.com/amgen ... biancoj@amgen.com....
Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral
Edit PR Newswire 09 May 2016
CAMBRIDGE, Mass., May 9, 2016 /PRNewswire/ -- Amgen (NASDAQ. AMGN) and LabCentral announced today that Platelet BioGenesis is an Amgen's 2016 winner of the highly competitive Golden Ticket award, which underwrites the cost of a lab bench for a Platelet BioGenesis scientist in LabCentral's ... ....
San Luis Obispo County, California To Host Stage 4 of Amgen Tour of California in ...
Edit PR Newswire 09 May 2016
SAN LUIS OBISPO, Calif., May 9, 2016 /PRNewswire-USNewswire/ -- The 2016 Amgen Tour of California, which enters its second decade as America's most prestigious annual cycling event, will feature San Luis Obispo County for the third straight year as part of this year's epic event ... ....
- 1
- 2
- 3
- 4
- 5
- Next page »
